I think Dosdog is a downramper.
Every new medicine is novel to a degree...logically you should never invest in biopharma then....
Secondly (if my memory serves me correct) Recce is only attracted to and only binds to bacterial cells, a heat seeking missile as such. This trait is relatively common in emerging biopharma. So how is disrupting the ftsz process in a soon to be exploded cell an issue?
Ann: R327 Demonstrates World First Multiple Mechanisms of Action, page-48
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
-0.005(1.67%) |
Mkt cap ! $85.06M | |||
| Open | High | Low | Value | Volume |
| 29.5¢ | 29.5¢ | 29.0¢ | $38.76K | 133.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 135000 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 9819 | 2 |
View Market Depth
| Last trade - 16.10pm 23/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |